Skip to main content
Top
Published in: Gut Pathogens 1/2022

Open Access 01-12-2022 | SARS-CoV-2 | Research

Comparison of SARS-CoV-2 spike RNA sequences in feces and nasopharynx indicates intestinal replication

Authors: Thomas Beck-Friis, Ambjörn Kärmander, Kristina Nyström, Hao Wang, Magnus Gisslén, Lars-Magnus Andersson, Heléne Norder

Published in: Gut Pathogens | Issue 1/2022

Login to get access

Abstract

Background

Little is known of possible selection and replication of SARS-CoV-2 in the intestines and if viral load in feces is associated with severity of disease. Therefore, sequence variations of the spike region in strains collected from feces and nasopharynx (NPH) from the same patients were compared. It was also investigated whether viral load in feces related to severity of COVID-19 in hospitalized patients.

Results

SARS-CoV-2 RNA was found in 88 (79%) fecal samples from 112 patients. The complete spike region could be sequenced in 15 fecal and 14 NPH samples. Fourteen Alpha-variants and one Beta-variant of SARS-CoV-2 were identified. The majority of the viral genetic variants (viral populations) in two fecal samples, but none in NPH, had a reversion of the H69/V70 amino acid deletion normally seen in the Alpha variants. Nine fecal samples contained up to nine minority variants, each which may constitute a separate viral population. Five NPH samples had one genetic variant each, and one NPH sample contained nine minority populations of SARS-CoV-2 spike genes.

Conclusions

The higher genomic diversity of SARS-CoV-2 in feces compared to NPH, and the reversion of the H69/V70 deletion in Alpha variants from feces indicate a selection of viral strains and replication of SARS-CoV-2 in the gastrointestinal tract.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wong MC, Huang J, Lai C, Ng R, Chan FKL, Chan PKS. Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis. J Infect. 2020;81(2):e31–8.CrossRef Wong MC, Huang J, Lai C, Ng R, Chan FKL, Chan PKS. Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis. J Infect. 2020;81(2):e31–8.CrossRef
3.
go back to reference Faridl M, Mellyani K, Khoirunnisa K, Septiani P, Giri-Rachman EA, Nugrahapraja H, et al. RNA-seq analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic COVID-19 patients. Int J Infect Dis. 2022;122:449–60.CrossRef Faridl M, Mellyani K, Khoirunnisa K, Septiani P, Giri-Rachman EA, Nugrahapraja H, et al. RNA-seq analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic COVID-19 patients. Int J Infect Dis. 2022;122:449–60.CrossRef
5.
go back to reference Troyano-Hernáez P, Reinosa R, Holguín Á. Evolution of SARS-CoV-2 in Spain during the first two years of the pandemic: circulating variants, amino acid conservation, and genetic variability in structural, non-structural, and accessory proteins. Int J Mol Sci. 2022;23(12):6394.CrossRef Troyano-Hernáez P, Reinosa R, Holguín Á. Evolution of SARS-CoV-2 in Spain during the first two years of the pandemic: circulating variants, amino acid conservation, and genetic variability in structural, non-structural, and accessory proteins. Int J Mol Sci. 2022;23(12):6394.CrossRef
6.
go back to reference Van Elslande J, Kerckhofs F, Cuypers L, Wollants E, Potter B, Vankeerberghen A, et al. Two separate clusters of SARS-CoV-2 delta variant infections in a group of 41 students travelling from India: an illustration of the need for rigorous testing and quarantine. Viruses. 2022;14(6):1198.CrossRef Van Elslande J, Kerckhofs F, Cuypers L, Wollants E, Potter B, Vankeerberghen A, et al. Two separate clusters of SARS-CoV-2 delta variant infections in a group of 41 students travelling from India: an illustration of the need for rigorous testing and quarantine. Viruses. 2022;14(6):1198.CrossRef
8.
go back to reference Papoutsis A, Borody T, Dolai S, Daniels J, Steinberg S, Barrows B, et al. Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing. Gut Pathog. 2021;13(1):7.CrossRef Papoutsis A, Borody T, Dolai S, Daniels J, Steinberg S, Barrows B, et al. Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing. Gut Pathog. 2021;13(1):7.CrossRef
9.
go back to reference Li Y, Chen YI, Ni H, Yi BO, Zhang D, Zhang J, et al. Discovery and full genome characterization of SARS-CoV-2 in stool specimen from a recovered patient. China Pol J Microbiol. 2021;70(3):401–4.CrossRef Li Y, Chen YI, Ni H, Yi BO, Zhang D, Zhang J, et al. Discovery and full genome characterization of SARS-CoV-2 in stool specimen from a recovered patient. China Pol J Microbiol. 2021;70(3):401–4.CrossRef
10.
go back to reference Mohanty MC, Taur PD, Sawant UP, Yadav RM, Potdar V. Prolonged fecal shedding of SARS-CoV-2 in asymptomatic children with inborn errors of immunity. J Clin Immunol. 2021;41(8):1748–53.CrossRef Mohanty MC, Taur PD, Sawant UP, Yadav RM, Potdar V. Prolonged fecal shedding of SARS-CoV-2 in asymptomatic children with inborn errors of immunity. J Clin Immunol. 2021;41(8):1748–53.CrossRef
11.
go back to reference Xu Y, Kang L, Shen Z, Li X, Wu W, Ma W, et al. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence. J Genet Genom. 2020;47(10):610–7.CrossRef Xu Y, Kang L, Shen Z, Li X, Wu W, Ma W, et al. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence. J Genet Genom. 2020;47(10):610–7.CrossRef
12.
go back to reference Zhang Y, Chen C, Song Y, Zhu S, Wang D, Zhang H, et al. Excretion of SARS-CoV-2 through faecal specimens. Emerg Microbes Infect. 2020;9(1):2501–8.CrossRef Zhang Y, Chen C, Song Y, Zhu S, Wang D, Zhang H, et al. Excretion of SARS-CoV-2 through faecal specimens. Emerg Microbes Infect. 2020;9(1):2501–8.CrossRef
13.
go back to reference Characterisation WHOWGotC. Management of CI. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–7.CrossRef Characterisation WHOWGotC. Management of CI. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–7.CrossRef
15.
go back to reference Ohta T. Synonymous and nonsynonymous substitutions in mammalian genes and the nearly neutral theory. J Mol Evol. 1995;40(1):56–63.CrossRef Ohta T. Synonymous and nonsynonymous substitutions in mammalian genes and the nearly neutral theory. J Mol Evol. 1995;40(1):56–63.CrossRef
16.
go back to reference Meng B, Kemp SA, Papa G, Datir R, Ferreira I, Marelli S, et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the alpha variant B117. Cell Rep. 2021;35(13):109292.CrossRef Meng B, Kemp SA, Papa G, Datir R, Ferreira I, Marelli S, et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the alpha variant B117. Cell Rep. 2021;35(13):109292.CrossRef
17.
go back to reference Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021;18(4):269–83.CrossRef Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021;18(4):269–83.CrossRef
18.
go back to reference Lin W, Xie Z, Li Y, Li L, Wen C, Cao Y, et al. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. J Med Virol. 2021;93(2):794–802.CrossRef Lin W, Xie Z, Li Y, Li L, Wen C, Cao Y, et al. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. J Med Virol. 2021;93(2):794–802.CrossRef
19.
go back to reference Chen GQ, Luo WT, Zhao CH, Li CN, Hong ZS, Xia JY, et al. Comparison of clinical characteristics between fecal/perianal swab nucleic acid-positive and -negative patients with COVID-19. J Infect Dev Ctries. 2020;14(8):847–52.CrossRef Chen GQ, Luo WT, Zhao CH, Li CN, Hong ZS, Xia JY, et al. Comparison of clinical characteristics between fecal/perianal swab nucleic acid-positive and -negative patients with COVID-19. J Infect Dev Ctries. 2020;14(8):847–52.CrossRef
20.
go back to reference Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020;92(7):833–40.CrossRef Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020;92(7):833–40.CrossRef
21.
go back to reference Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443.CrossRef Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443.CrossRef
22.
go back to reference Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–9.CrossRef Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–9.CrossRef
23.
go back to reference Bushman FD, McCormick K, Sherrill-Mix S. Virus structures constrain transmission modes. Nat Microbiol. 2019;4(11):1778–80.CrossRef Bushman FD, McCormick K, Sherrill-Mix S. Virus structures constrain transmission modes. Nat Microbiol. 2019;4(11):1778–80.CrossRef
24.
go back to reference Liu Q, Wang HY. Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis. Vet Res Commun. 2021;45(2–3):75–86.CrossRef Liu Q, Wang HY. Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis. Vet Res Commun. 2021;45(2–3):75–86.CrossRef
25.
go back to reference Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza a viruses. Microbiol Rev. 1992;56(1):152–79.CrossRef Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza a viruses. Microbiol Rev. 1992;56(1):152–79.CrossRef
26.
go back to reference Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727–32.CrossRef Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727–32.CrossRef
27.
go back to reference Hikmet F, Mear L, Edvinsson A, Micke P, Uhlen M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020;16(7):e9610.CrossRef Hikmet F, Mear L, Edvinsson A, Micke P, Uhlen M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020;16(7):e9610.CrossRef
28.
go back to reference Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7.CrossRef Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7.CrossRef
29.
go back to reference Suarez-Farinas M, Tokuyama M, Wei G, Huang R, Livanos A, Jha D, et al. Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2-related disease. Gastroenterology. 2021;160(1):287-301 e20.CrossRef Suarez-Farinas M, Tokuyama M, Wei G, Huang R, Livanos A, Jha D, et al. Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2-related disease. Gastroenterology. 2021;160(1):287-301 e20.CrossRef
31.
go back to reference Hirose R, Nakaya T, Naito Y, Daidoji T, Watanabe Y, Yasuda H, et al. Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices. J Infect Dis. 2017;216(1):105–9.CrossRef Hirose R, Nakaya T, Naito Y, Daidoji T, Watanabe Y, Yasuda H, et al. Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices. J Infect Dis. 2017;216(1):105–9.CrossRef
32.
go back to reference Fujimoto Y, Ito H, Ono E, Kawaoka Y, Ito T. The low-pH resistance of neuraminidase is essential for the replication of influenza a virus in duck intestine following infection via the oral route. J Virol. 2016;90(8):4127–32.CrossRef Fujimoto Y, Ito H, Ono E, Kawaoka Y, Ito T. The low-pH resistance of neuraminidase is essential for the replication of influenza a virus in duck intestine following infection via the oral route. J Virol. 2016;90(8):4127–32.CrossRef
33.
go back to reference Krempl C, Schultze B, Laude H, Herrler G. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol. 1997;71(4):3285–7.CrossRef Krempl C, Schultze B, Laude H, Herrler G. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol. 1997;71(4):3285–7.CrossRef
34.
go back to reference Xie X, Liu Y, Liu J, Zhang X, Zou J, Fontes-Garfias CR, et al. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021;27(4):620–1.CrossRef Xie X, Liu Y, Liu J, Zhang X, Zou J, Fontes-Garfias CR, et al. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021;27(4):620–1.CrossRef
35.
go back to reference Marklund E, Leach S, Axelsson H, Nystrom K, Norder H, Bemark M, et al. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS ONE. 2020;15(10):e0241104.CrossRef Marklund E, Leach S, Axelsson H, Nystrom K, Norder H, Bemark M, et al. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS ONE. 2020;15(10):e0241104.CrossRef
36.
go back to reference Yilmaz A, Marklund E, Andersson M, Nilsson S, Andersson LM, Lindh M, et al. Upper respiratory tract levels of severe acute respiratory syndrome coronavirus 2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical coronavirus disease 2019. J Infect Dis. 2021;223(1):15–8.CrossRef Yilmaz A, Marklund E, Andersson M, Nilsson S, Andersson LM, Lindh M, et al. Upper respiratory tract levels of severe acute respiratory syndrome coronavirus 2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical coronavirus disease 2019. J Infect Dis. 2021;223(1):15–8.CrossRef
38.
go back to reference Saguti F, Magnil E, Enache L, Churqui MP, Johansson A, Lumley D, et al. Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19. Water Res. 2021;189:116620.CrossRef Saguti F, Magnil E, Enache L, Churqui MP, Johansson A, Lumley D, et al. Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19. Water Res. 2021;189:116620.CrossRef
39.
go back to reference Ringlander J, Olausson J, Nystrom K, Harnqvist T, Jakobsson HE, Lindh M. Recurrent and persistent infection with SARS-CoV-2—epidemiological data and case reports from Western Sweden, 2020. Infect Dis. 2021;53(12):900–7.CrossRef Ringlander J, Olausson J, Nystrom K, Harnqvist T, Jakobsson HE, Lindh M. Recurrent and persistent infection with SARS-CoV-2—epidemiological data and case reports from Western Sweden, 2020. Infect Dis. 2021;53(12):900–7.CrossRef
41.
go back to reference Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30(12):2725–9.CrossRef Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30(12):2725–9.CrossRef
Metadata
Title
Comparison of SARS-CoV-2 spike RNA sequences in feces and nasopharynx indicates intestinal replication
Authors
Thomas Beck-Friis
Ambjörn Kärmander
Kristina Nyström
Hao Wang
Magnus Gisslén
Lars-Magnus Andersson
Heléne Norder
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2022
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-022-00509-w

Other articles of this Issue 1/2022

Gut Pathogens 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.